2026-03-06T20:40:09Zhttps://uvadoc.uva.es/oai/requestoai:uvadoc.uva.es:10324/429332021-09-27T09:41:43Zcom_10324_41462com_10324_954com_10324_894col_10324_41463
Mendoza, Carmen de
Roc, Lourdes
Benito, Rafael
Reina, Gabriel
Ramos, José Manuel
Gómez, César
Aguilera, Antonio
Rodríguez Iglesias, Manuel
García Costa, Juan
Fernández Alonso, Mirian
Soriano, Vicente
2020-10-13T11:56:11Z
2020-10-13T11:56:11Z
2019
BMC Infectious Diseases, 2019, vol.19, n. 1, art. 706
1471-2334
http://uvadoc.uva.es/handle/10324/42933
10.1186/s12879-019-4346-z
1
BMC Infectious Diseases
19
1471-2334
Producción Científica
HTLV-1 infection is a neglected disease, despite infecting 10–15 million people worldwide and severe illnesses develop in 10% of carriers lifelong. Acknowledging a greater risk for developing HTLV-1 associated illnesses due to immunosuppression, screening is being widely considered in the transplantation setting. Herein, we report the experience with universal HTLV testing of donors and recipients of solid organ transplants in a survey conducted in Spain.
application/pdf
eng
BioMed Central (BMC)
info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-nd/4.0/
© BioMed Central
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
HTLV-1
Trasplante
Paraparesia espástica tropical
Leucemia de células T adultas
2420 Virología
HTLV-1 infection in solid organ transplant donors and recipients in Spain
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-4346-z
SI